CC[C@H](C)[C@H](NC(=O)N(CCC#N)CCN(CCN(C(=O)N[C@@H](Cc1ccccc1)C(=O)OC)c1ccccc1)C(=O)N[C@H](C(=O)OC)C(C)C)C(=O)OC
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?